Search results
Results From The WOW.Com Content Network
Alcon offices in Johns Creek, Georgia. Alcon Inc. ( German: Alcon AG) is a Swiss-American pharmaceutical and medical device company specializing in eye care products. It has a paper headquarters in Geneva, Switzerland but its operational headquarters are in Fort Worth, Texas, United States, where it employs about 4,500 people. [2]
Alcoa. Alcoa Corporation (an acronym for " Aluminum Company of America ") is a Pittsburgh -based industrial corporation. It is the world's eighth-largest producer of aluminum. [ 2][ 3] Alcoa conducts operations in 10 countries. Alcoa is a major producer of primary aluminum, fabricated aluminum, and alumina combined, through its active and ...
Alcon is the world's largest and most profitable eye care company, Novartis said in a statement, with 2009 annual sales of $6.5 billion and net income of $2 billion.
Allergan plc is an American, Irish-domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. [1] [2] [3] The company is the maker of Botox.
Alcon Laboratories, already one of the largest employers and taxpayers in Tarrant County, is exploring a 250,000-square-foot expansion. Alcon Laboratories is considering a major $100M expansion of ...
Paramount Global's ( PARA) plans to merge with production studio Skydance Media could set off a dealmaking spree in the media industry as it grapples with traditional TV's decline. On Sunday ...
The following is a list of publicly traded companies having the greatest market capitalization, sometimes described as their "market value": [1] Market capitalization is calculated by multiplying the share price on a selected day and the number of outstanding shares on that day. The list is expressed in USD millions, using exchange rates from ...
Novartis (NVS) has worked aggressively to purchase Alcon (ACL), a major eye-care company, from Nestlé. The deal-making started a couple of years ago when Novartis shelled out $10.4 billion to ...